APA (7th ed.) Citation

J, A., E, d. L., S, S., L, B., P, S., C, B., . . . JM, M. (2025). Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial). The Journal of infection, 91(5), 106651. https://doi.org/10.1016/j.jinf.2025.106651

Chicago Style (17th ed.) Citation

J, Ambrosioni, et al. "Bictegravir/emtricitabine/tenofovir Alafenamide for Primary HIV Infection: Efficacy, Safety and Impact on Viral Reservoir (the BIC-PHI Clinical Trial)." The Journal of Infection 91, no. 5 (2025): 106651. https://doi.org/10.1016/j.jinf.2025.106651.

MLA (9th ed.) Citation

J, Ambrosioni, et al. "Bictegravir/emtricitabine/tenofovir Alafenamide for Primary HIV Infection: Efficacy, Safety and Impact on Viral Reservoir (the BIC-PHI Clinical Trial)." The Journal of Infection, vol. 91, no. 5, 2025, p. 106651, https://doi.org/10.1016/j.jinf.2025.106651.